The Role of Genomics and Proteomics in Lung Cancer Early Detection and Treatment
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The Role of Genomics and Proteomics in Lung Cancer Early Detection and Treatment
Authors
Keywords
-
Journal
Cancers
Volume 14, Issue 20, Pages 5144
Publisher
MDPI AG
Online
2022-10-21
DOI
10.3390/cancers14205144
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Predictive value of tumor mutational burden for immunotherapy in non-small cell lung cancer: A systematic review and meta-analysis
- (2022) Guangxian Meng et al. PLoS One
- Predicting EGFR and PD-L1 Status in NSCLC Patients Using Multitask AI System Based on CT Images
- (2022) Chengdi Wang et al. Frontiers in Immunology
- MicroRNA-21 as a diagnostic and prognostic biomarker of lung cancer: a systematic review and meta-analysis
- (2022) Wei Wang et al. BIOSCIENCE REPORTS
- Blood-based tumor mutational burden as a biomarker for atezolizumab in non-small cell lung cancer: the phase 2 B-F1RST trial
- (2022) Edward S. Kim et al. NATURE MEDICINE
- Application of Artificial Intelligence in Lung Cancer
- (2022) Hwa-Yen Chiu et al. Cancers
- Artificial intelligence–powered programmed death ligand 1 analyser reduces interobserver variation in tumour proportion score for non–small cell lung cancer with better prediction of immunotherapy response
- (2022) Sangjoon Choi et al. EUROPEAN JOURNAL OF CANCER
- ROS1-positive non-small cell lung cancer (NSCLC): biology, diagnostics, therapeutics and resistance
- (2022) Zhi-Qiong Yu et al. JOURNAL OF DRUG TARGETING
- Artificial Intelligence-Assisted Score Analysis for Predicting the Expression of the Immunotherapy Biomarker PD-L1 in Lung Cancer
- (2022) Guoping Cheng et al. Frontiers in Immunology
- DNA Methylation Biomarkers for Prediction of Response to Platinum-Based Chemotherapy: Where Do We Stand?
- (2022) Nuno Tiago Tavares et al. Cancers
- Predictive and Prognostic Value of Non-Coding RNA in Breast Cancer
- (2022) Navid Sobhani et al. Cancers
- Identification of hub genes, modules and biological pathways associated with lung adenocarcinoma: A system biology approach
- (2022) Raheleh Roudi et al. Gene Reports
- Current Status and Future Perspectives of Liquid Biopsy in Small Cell Lung Cancer
- (2021) Patricia Mondelo-Macía et al. Biomedicines
- Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2021) Hyuna Sung et al. CA-A CANCER JOURNAL FOR CLINICIANS
- LC-MS/MS-Based Quantitative Proteomics Analysis of Different Stages of Non-Small-Cell Lung Cancer
- (2021) Murong Zhou et al. Biomed Research International
- DNA methylation of PTGER4 in peripheral blood plasma helps to distinguish between lung cancer, benign pulmonary nodules and chronic obstructive pulmonary disease patients
- (2021) Lea M. Schotten et al. EUROPEAN JOURNAL OF CANCER
- Immune checkpoint inhibitors and chemotherapy in first-line NSCLC: a meta-analysis
- (2021) Fausto Petrelli et al. Immunotherapy
- Single-cell profiling of tumor heterogeneity and the microenvironment in advanced non-small cell lung cancer
- (2021) Fengying Wu et al. Nature Communications
- Genomic Characterization of Concurrent Alterations in Non-Small Cell Lung Cancer (NSCLC) Harboring Actionable Mutations
- (2021) Antonio Passaro et al. Cancers
- Artificial intelligence-assisted system for precision diagnosis of PD-L1 expression in non-small cell lung cancer
- (2021) Jianghua Wu et al. MODERN PATHOLOGY
- Targeting the PI3K/AKT/mTOR Signaling Pathway in Lung Cancer: An Update Regarding Potential Drugs and Natural Products
- (2021) Iksen et al. MOLECULES
- Proteomic biomarkers of non-small cell lung cancer patients
- (2021) Kamila Baran et al. Advances in Respiratory Medicine
- DNA methylation in lung cancer patients: Opening a "window of life" under precision medicine
- (2021) Runzhang Liang et al. BIOMEDICINE & PHARMACOTHERAPY
- Artificial intelligence in oncology
- (2020) Hideyuki Shimizu et al. CANCER SCIENCE
- Aberrant DNA methylation profile exacerbates inflammation and neurodegeneration in multiple sclerosis patients
- (2020) Naiara Celarain et al. Journal of Neuroinflammation
- Pan-cancer analysis of whole genomes
- (2020) NATURE
- Evaluating the Use of Circulating MicroRNA Profiles for Lung Cancer Detection in Symptomatic Patients
- (2020) Tobias Fehlmann et al. JAMA Oncology
- Microbiome analyses of blood and tissues suggest cancer diagnostic approach
- (2020) Gregory D. Poore et al. NATURE
- Recent advances in mass spectrometry based clinical proteomics: applications to cancer research
- (2020) Andrew Macklin et al. Clinical Proteomics
- Atezolizumab for First-Line Treatment of PD-L1–Selected Patients with NSCLC
- (2020) Roy S. Herbst et al. NEW ENGLAND JOURNAL OF MEDICINE
- Artificial Intelligence Applied to Breast MRI for Improved Diagnosis
- (2020) Yulei Jiang et al. RADIOLOGY
- Challenges of PD-L1 testing in non-small cell lung cancer and beyond
- (2020) Minyu Wang et al. Journal of Thoracic Disease
- Clinical Application of the FoundationOne CDx Assay to Therapeutic Decision‐Making for Patients with Advanced Solid Tumors
- (2020) Masayuki Takeda et al. ONCOLOGIST
- ROS1-GOPC/FIG: a novel gene fusion in hepatic angiosarcoma
- (2019) Eric I. Marks et al. Oncotarget
- Assessment of Blood Tumor Mutational Burden as a Potential Biomarker for Immunotherapy in Patients With Non–Small Cell Lung Cancer With Use of a Next-Generation Sequencing Cancer Gene Panel
- (2019) Zhijie Wang et al. JAMA Oncology
- Introduction to artificial intelligence in medicine
- (2019) Yoav Mintz et al. MINIMALLY INVASIVE THERAPY & ALLIED TECHNOLOGIES
- Crizotinib in Chinese Patients with ROS1-Rearranged Advanced Non‒Small-Cell Lung Cancer in Routine Clinical Practice
- (2019) Chang Liu et al. Targeted Oncology
- Urinary exosomal proteins as (pan‐)cancer biomarkers: insights from the proteome
- (2019) L. Ayse Erozenci et al. FEBS LETTERS
- Anti-PD-1 versus anti-PD-L1 therapy in patients with pretreated advanced non-small-cell lung cancer: a meta-analysis
- (2019) Alfredo Tartarone et al. Future Oncology
- Proteomics analysis of human serum of patients with non‐small‐cell lung cancer reveals proteins as diagnostic biomarker candidates
- (2019) Mariarosaria Boccellino et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Frequency and clinical features of BRAF mutations among patients with stage III/IV lung adenocarcinoma without EGFR/ALK aberrations
- (2019) Ho Cheol Kim et al. OncoTargets and Therapy
- Comparison of Deep Learning Approaches for Multi-Label Chest X-Ray Classification
- (2019) Ivo M. Baltruschat et al. Scientific Reports
- Circulating microRNA‐590‐5p acts as a liquid biopsy marker in non‐small cell lung cancer
- (2019) Akanksha Khandelwal et al. CANCER SCIENCE
- TARGETING EGFR PATHWAY IN METASTATIC COLORECTAL CANCER- TUMOUR HETEROGENIETY AND CONVERGENT EVOLUTION
- (2019) Khurum Khan et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Plasma Proteome Profiling to detect and avoid sample‐related biases in biomarker studies
- (2019) Philipp E Geyer et al. EMBO Molecular Medicine
- Non–Small Cell Lung Cancer: Epidemiology, Screening, Diagnosis, and Treatment
- (2019) Narjust Duma et al. MAYO CLINIC PROCEEDINGS
- LBA83Final efficacy results from B-F1RST, a prospective phase II trial evaluating blood-based tumour mutational burden (bTMB) as a predictive biomarker for atezolizumab (atezo) in 1L non-small cell lung cancer (NSCLC)
- (2019) M Socinski et al. ANNALS OF ONCOLOGY
- Latest techniques to study DNA methylation
- (2019) Quentin Gouil et al. Essays in Biochemistry
- Tumor Mutational Burden and Efficacy of Immune Checkpoint Inhibitors: A Systematic Review and Meta-Analysis
- (2019) Jong Yeob Kim et al. Cancers
- Molecular Targeting Therapy against EGFR Family in Breast Cancer: Progress and Future Potentials
- (2019) Amaia Eleonora Maennling et al. Cancers
- Lifecycle Regulation of Artificial Intelligence– and Machine Learning–Based Software Devices in Medicine
- (2019) Thomas J. Hwang et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Development and Analytical Validation of a DNA Dual-Strand Approach for the US Food and Drug Administration–Approved Next-Generation Sequencing–Based Praxis Extended RAS Panel for Metastatic Colorectal Cancer Samples
- (2019) Nitin Udar et al. JOURNAL OF MOLECULAR DIAGNOSTICS
- The serum-based VeriStrat® test is associated with proinflammatory reactants and clinical outcome in non-small cell lung cancer patients
- (2018) Mary Jo Fidler et al. BMC CANCER
- Phase II Study of Crizotinib in East Asian Patients With ROS1-Positive Advanced Non–Small-Cell Lung Cancer
- (2018) Yi-Long Wu et al. JOURNAL OF CLINICAL ONCOLOGY
- The incidence of brain metastases in stage IV ROS1 -rearranged non-small cell lung cancer and rate of central nervous system progression on crizotinib
- (2018) Tejas Patil et al. Journal of Thoracic Oncology
- Prognostic role of the VeriStrat test in first line patients with non-small cell lung cancer treated with platinum-based chemotherapy
- (2018) Francesco Grossi et al. LUNG CANCER
- Two plasma microRNA panels for diagnosis and subtype discrimination of lung cancer
- (2018) Shaohua Lu et al. LUNG CANCER
- Management of acquired resistance to EGFR TKI–targeted therapy in advanced non-small cell lung cancer
- (2018) Shang-Gin Wu et al. Molecular Cancer
- RAS–MAPK Reactivation Facilitates Acquired Resistance inFGFR1-Amplified Lung Cancer and Underlies a Rationale for Upfront FGFR–MEK Blockade
- (2018) Bruno Bockorny et al. MOLECULAR CANCER THERAPEUTICS
- Author Correction: Analysis of DNA methylation in cancer: location revisited
- (2018) Alexander Koch et al. Nature Reviews Clinical Oncology
- Quantitative assessment of gene promoter methylation in non‑small cell lung cancer using methylation‑sensitive high‑resolution melting
- (2018) Fangming Liu et al. Oncology Letters
- Automated Diagnosis of Plus Disease in Retinopathy of Prematurity Using Deep Convolutional Neural Networks
- (2018) James M. Brown et al. JAMA Ophthalmology
- Urine Proteome Profiling Predicts Lung Cancer from Control Cases and Other Tumors
- (2018) Chunchao Zhang et al. EBioMedicine
- Multiple Biomarker Testing Tissue Consumption and Completion Rates With Single-gene Tests and Investigational Use of Oncomine Dx Target Test for Advanced Non–Small-cell Lung Cancer: A Single-center Analysis
- (2018) Tiffany M. Yu et al. Clinical Lung Cancer
- A radiomics approach to assess tumour-infiltrating CD8 cells and response to anti-PD-1 or anti-PD-L1 immunotherapy: an imaging biomarker, retrospective multicohort study
- (2018) Roger Sun et al. LANCET ONCOLOGY
- Blood-based tumor mutational burden as a predictor of clinical benefit in non-small-cell lung cancer patients treated with atezolizumab
- (2018) David R. Gandara et al. NATURE MEDICINE
- Classification and mutation prediction from non–small cell lung cancer histopathology images using deep learning
- (2018) Nicolas Coudray et al. NATURE MEDICINE
- Distribution of KRAS, DDR2, and TP53 gene mutations in lung cancer: An analysis of Iranian patients
- (2018) Zahra Fathi et al. PLoS One
- Detection of lung cancer with electronic nose and logistic regression analysis
- (2018) Madara Tirzīte et al. Journal of Breath Research
- Tumor mutational burden is a determinant of immune-mediated survival in breast cancer
- (2018) Alexandra Thomas et al. OncoImmunology
- A Phase 1 Study of Alpelisib (BYL719), an α- Specific PI3K Inhibitor, in Japanese Patients with Advanced Solid Tumors
- (2018) Yuichi Ando et al. CANCER SCIENCE
- A two-miRNA signature (miR-33a-5p and miR-128-3p) in whole blood as potential biomarker for early diagnosis of lung cancer
- (2018) Jinchang Pan et al. Scientific Reports
- Very early response of circulating tumour–derived DNA in plasma predicts efficacy of nivolumab treatment in patients with non–small cell lung cancer
- (2017) Yuki Iijima et al. EUROPEAN JOURNAL OF CANCER
- The power of tears: how tear proteomics research could revolutionize the clinic
- (2017) Lei Zhou et al. Expert Review of Proteomics
- Identification of Proteomic Features To Distinguish Benign Pulmonary Nodules from Lung Adenocarcinoma
- (2017) Simona G. Codreanu et al. JOURNAL OF PROTEOME RESEARCH
- First-line pembrolizumab in cisplatin-ineligible patients with locally advanced and unresectable or metastatic urothelial cancer (KEYNOTE-052): a multicentre, single-arm, phase 2 study
- (2017) Arjun V Balar et al. LANCET ONCOLOGY
- EGFR heterogeneity and implications for therapeutic intervention in glioblastoma
- (2017) Eskil Eskilsson et al. NEURO-ONCOLOGY
- Potential circulating miRNA signature for early detection of NSCLC
- (2017) Ayda Arab et al. Cancer Genetics
- A plasma miRNA signature for lung cancer early detection
- (2017) Qixin Leng et al. Oncotarget
- Gene methylation as a powerful biomarker for detection and screening of non-small cell lung cancer in blood
- (2017) Bao-hua Wang et al. Oncotarget
- Bronchoalveolar Lavage Proteomics in Patients with Suspected Lung Cancer
- (2017) Ana Sofia Carvalho et al. Scientific Reports
- Identification of MST1 as a potential early detection biomarker for colorectal cancer through a proteomic approach
- (2017) Jiekai Yu et al. Scientific Reports
- Identification of GlcNAcylated alpha-1-antichymotrypsin as an early biomarker in human non-small-cell lung cancer by quantitative proteomic analysis with two lectins
- (2016) Yanxia Jin et al. BRITISH JOURNAL OF CANCER
- Detection of Therapeutically Targetable Driver and Resistance Mutations in Lung Cancer Patients by Next-Generation Sequencing of Cell-Free Circulating Tumor DNA
- (2016) J. C. Thompson et al. CLINICAL CANCER RESEARCH
- A Novel Epigenetic Signature for Early Diagnosis in Lung Cancer
- (2016) A. Diaz-Lagares et al. CLINICAL CANCER RESEARCH
- Early Detection of Lung Cancer Using DNA Promoter Hypermethylation in Plasma and Sputum
- (2016) Alicia Hulbert et al. CLINICAL CANCER RESEARCH
- On the pharmacogenetics of non-small cell lung cancer treatment
- (2016) Mariacarmela Santarpia et al. Expert Opinion on Drug Metabolism & Toxicology
- Exhaled breath condensate as a source of biomarkers for lung carcinomas. A focus on genetic and epigenetic markers-A mini-review
- (2016) Omar Youssef et al. GENES CHROMOSOMES & CANCER
- Evaluation of anaplastic lymphoma kinase expression in nonsmall cell lung cancer;a tissue microarray analysis
- (2016) Mitra Mehrazma et al. Journal of Cancer Research and Therapeutics
- Discovery of potential protein biomarkers of lung adenocarcinoma in bronchoalveolar lavage fluid by SWATH MS data-independent acquisition and targeted data extraction
- (2016) I. Ortea et al. Journal of Proteomics
- Exosomal Proteins as Diagnostic Biomarkers in Lung Cancer
- (2016) Birgitte Sandfeld-Paulsen et al. Journal of Thoracic Oncology
- Atezolizumab versus docetaxel for patients with previously treated non-small-cell lung cancer (POPLAR): a multicentre, open-label, phase 2 randomised controlled trial
- (2016) Louis Fehrenbacher et al. LANCET
- Identification and Characterization of Potential Biomarkers by Quantitative Tissue Proteomics of Primary Lung Adenocarcinoma
- (2016) Chiung-Hung Hsu et al. MOLECULAR & CELLULAR PROTEOMICS
- Exosomal proteins as prognostic biomarkers in non-small cell lung cancer
- (2016) B. Sandfeld-Paulsen et al. Molecular Oncology
- Pembrolizumab versus Chemotherapy for PD-L1–Positive Non–Small-Cell Lung Cancer
- (2016) Martin Reck et al. NEW ENGLAND JOURNAL OF MEDICINE
- Mutation and prognostic analyses of PIK3CA in patients with completely resected lung adenocarcinoma
- (2016) Zhengbo Song et al. Cancer Medicine
- Methylation of the DCLK1 promoter region in circulating free DNA and its prognostic value in lung cancer patients
- (2015) T. Powrózek et al. Clinical & Translational Oncology
- Early Detection of Lung Cancer in Serum by a Panel of MicroRNA Biomarkers
- (2015) Ping Wang et al. Clinical Lung Cancer
- Memorial Sloan Kettering-Integrated Mutation Profiling of Actionable Cancer Targets (MSK-IMPACT)
- (2015) Donavan T. Cheng et al. JOURNAL OF MOLECULAR DIAGNOSTICS
- Proteomic Profiling of Paclitaxel Treated Cells Identifies a Novel Mechanism of Drug Resistance Mediated by PDCD4
- (2015) Hui Xu et al. JOURNAL OF PROTEOME RESEARCH
- Machine learning applications in genetics and genomics
- (2015) Maxwell W. Libbrecht et al. NATURE REVIEWS GENETICS
- Pembrolizumab for the Treatment of Non–Small-Cell Lung Cancer
- (2015) Edward B. Garon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Review The Cancer Genome Atlas (TCGA): an immeasurable source of knowledge
- (2015) Katarzyna Tomczak et al. Wspolczesna Onkologia-Contemporary Oncology
- Advances in EGFR as a Predictive Marker in Lung Adenocarcinoma
- (2015) Farah K. Khalil et al. Cancer Control
- Abstract 1184: Modeling mechanisms of resistance of epidermal growth factor receptor (EGFR) mutations to targeted drugs through patient-derived xenografts (PDX) of non-small cell lung cancer (NSCLC)
- (2015) Erin L. Stewart et al. CANCER RESEARCH
- MicroRNA-486 as a Biomarker for Early Diagnosis and Recurrence of Non-Small Cell Lung Cancer
- (2015) Wanshuai Li et al. PLoS One
- Proteomic Analysis of Urine to Identify Breast Cancer Biomarker Candidates Using a Label-Free LC-MS/MS Approach
- (2015) Julia Beretov et al. PLoS One
- PIK3CA mutations in non-small cell lung cancer (NSCLC): Genetic heterogeneity, prognostic impact and incidence of prior malignancies
- (2015) Matthias Scheffler et al. Oncotarget
- Association of PD-1, PD-1 Ligands, and Other Features of the Tumor Immune Microenvironment with Response to Anti-PD-1 Therapy
- (2014) J. M. Taube et al. CLINICAL CANCER RESEARCH
- Identification of ENO1 As a Potential Sputum Biomarker for Early-Stage Lung Cancer by Shotgun Proteomics
- (2014) Lei Yu et al. Clinical Lung Cancer
- Clinical Utility of a Plasma-Based miRNA Signature Classifier Within Computed Tomography Lung Cancer Screening: A Correlative MILD Trial Study
- (2014) Gabriella Sozzi et al. JOURNAL OF CLINICAL ONCOLOGY
- Predictive value of a proteomic signature in patients with non-small-cell lung cancer treated with second-line erlotinib or chemotherapy (PROSE): a biomarker-stratified, randomised phase 3 trial
- (2014) Vanesa Gregorc et al. LANCET ONCOLOGY
- Septin 9 promoter region methylation in free circulating DNA—potential role in noninvasive diagnosis of lung cancer: preliminary report
- (2014) Tomasz Powrózek et al. MEDICAL ONCOLOGY
- Comprehensive molecular profiling of lung adenocarcinoma
- (2014) Eric A. Collisson et al. NATURE
- Genetic Basis for Clinical Response to CTLA-4 Blockade in Melanoma
- (2014) Alexandra Snyder et al. NEW ENGLAND JOURNAL OF MEDICINE
- Crizotinib in ROS1-Rearranged Non–Small-Cell Lung Cancer
- (2014) Alice T. Shaw et al. NEW ENGLAND JOURNAL OF MEDICINE
- Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach
- (2014) Hugo J. W. L. Aerts et al. Nature Communications
- ROS1-Rearranged Lung Cancer
- (2013) Akihiko Yoshida et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Identification ofROS1rearrangement in gastric adenocarcinoma
- (2013) Jeeyun Lee et al. CANCER
- Phase I Safety, Pharmacokinetic, and Pharmacodynamic Study of SAR245408 (XL147), an Oral Pan-Class I PI3K Inhibitor, in Patients with Advanced Solid Tumors
- (2013) G. I. Shapiro et al. CLINICAL CANCER RESEARCH
- Digital PCR quantification of miRNAs in sputum for diagnosis of lung cancer
- (2013) Ning Li et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Potentialities of aberrantly methylated circulating DNA for diagnostics and post-treatment follow-up of lung cancer patients
- (2013) Anastasia A. Ponomaryova et al. LUNG CANCER
- ROS1 and ALK Fusions in Colorectal Cancer, with Evidence of Intratumoral Heterogeneity for Molecular Drivers
- (2013) Dara L. Aisner et al. MOLECULAR CANCER RESEARCH
- TCPA: a resource for cancer functional proteomics data
- (2013) Jun Li et al. NATURE METHODS
- Molecular targets for cancer therapy in the PI3K/AKT/mTOR pathway
- (2013) Jiri Polivka et al. PHARMACOLOGY & THERAPEUTICS
- Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal
- (2013) J. Gao et al. Science Signaling
- Lung cancer survival and stage at diagnosis in Australia, Canada, Denmark, Norway, Sweden and the UK: a population-based study, 2004–2007
- (2013) Sarah Walters et al. THORAX
- ROS1 Rearrangements Define a Unique Molecular Class of Lung Cancers
- (2012) Kristin Bergethon et al. JOURNAL OF CLINICAL ONCOLOGY
- Prognostic and Predictive Role of the VeriStrat Plasma Test in Patients with Advanced Non–Small-Cell Lung Cancer Treated with Erlotinib or Placebo in the NCIC Clinical Trials Group BR.21 Trial
- (2012) David P. Carbone et al. Journal of Thoracic Oncology
- Methylation of TMEFF2 gene in tissue and serum DNA from patients with non-small cell lung cancer
- (2012) Su Man Lee et al. MOLECULES AND CELLS
- RET, ROS1 and ALK fusions in lung cancer
- (2012) Kengo Takeuchi et al. NATURE MEDICINE
- Methylation of multiple genes as a candidate biomarker in non-small cell lung cancer
- (2011) Youwei Zhang et al. CANCER LETTERS
- Clinical Features and Outcome of Patients With Non–Small-Cell Lung Cancer Harboring BRAF Mutations
- (2011) Antonio Marchetti et al. JOURNAL OF CLINICAL ONCOLOGY
- miR-1254 and miR-574-5p: Serum-Based microRNA Biomarkers for Early-Stage Non-small Cell Lung Cancer
- (2011) Kristen M. Foss et al. Journal of Thoracic Oncology
- SHOX2 DNA Methylation Is a Biomarker for the Diagnosis of Lung Cancer in Plasma
- (2011) Christoph Kneip et al. Journal of Thoracic Oncology
- Changes in Plasma Mass-Spectral Profile in Course of Treatment of Non-small Cell Lung Cancer Patients with Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors
- (2011) Chiara Lazzari et al. Journal of Thoracic Oncology
- Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening
- (2011) NEW ENGLAND JOURNAL OF MEDICINE
- Chromosome 3 Anomalies Investigated by Genome Wide SNP Analysis of Benign, Low Malignant Potential and Low Grade Ovarian Serous Tumours
- (2011) Ashley H. Birch et al. PLoS One
- International Cancer Genome Consortium Data Portal--a one-stop shop for cancer genomics data
- (2011) J. Zhang et al. Database-The Journal of Biological Databases and Curation
- Detection of Tumor Epidermal Growth Factor Receptor Pathway Dependence by Serum Mass Spectrometry in Cancer Patients
- (2010) C. H. Chung et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Genetics of lung-cancer susceptibility
- (2010) Paul Brennan et al. LANCET ONCOLOGY
- Classification by Mass Spectrometry Can Accurately and Reliably Predict Outcome in Patients with Non-small Cell Lung Cancer Treated with Erlotinib-Containing Regimen
- (2009) Stuart Salmon et al. Journal of Thoracic Oncology
- Screening for Epidermal Growth Factor Receptor Mutations in Lung Cancer
- (2009) Rafael Rosell et al. NEW ENGLAND JOURNAL OF MEDICINE
- PIK3CA Mutations and Copy Number Gains in Human Lung Cancers
- (2008) H. Yamamoto et al. CANCER RESEARCH
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now